Literature DB >> 32516422

Hydroa Vacciniforme-like Lymphoproliferative Disorder Treated with Intravenous Immunoglobulin: Long-term Remission Without Haematopoietic Stem Cell Transplantation or Chemotherapy.

YePing Ruan1, XiaoYan Shen, Ruofei Shi, XiaoQing Zhao, Jie Zheng.   

Abstract

Entities:  

Keywords:  chronic active Epstein–Barr virus infection, intravenous immunoglobulin; hydroa vacciniform-like lymphoproliferative disorder

Mesh：

Substances：

Year:  2020        PMID： 32516422      PMCID： PMC9175038          DOI： 10.2340/00015555-3556

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  11 in total

Review 1.  IVIG-mediated effector functions in autoimmune and inflammatory diseases.

Authors:  Caroline Galeotti; Srini V Kaveri; Jagadeesh Bayry
Journal:  Int Immunol       Date:  2017-12-30       Impact factor: 4.823

2.  Chronic active Epstein-Barr virus infection with cutaneous and sinus lymphoproliferation in a white female patient with 25 years' follow-up: an original case report.

Authors:  C Picard; S Gouarin; F Comoz; M Barreau; L Verneuil; X Troussard; A Dompmartin
Journal:  Br J Dermatol       Date:  2015-09-08       Impact factor: 9.302

Review 3.  Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome.

Authors:  Yoko Kano; Miyuki Inaoka; Keiichi Sakuma; Tetsuo Shiohara
Journal:  Toxicology       Date:  2005-04-15       Impact factor: 4.221

4.  Relative EBV antibody concentrations and cost of standard IVIG and CMV-IVIG for PTLD prophylaxis in solid organ transplant patients.

Authors:  L Ramirez-Avila; O B Garner; J D Cherry
Journal:  Pediatr Transplant       Date:  2014-07-07

5.  Hydroa vacciniforme-like lymphoproliferative disorder: Clinicopathologic study of 41 cases.

Authors:  Yanghe Liu; Cuiling Ma; Gang Wang; Lei Wang
Journal:  J Am Acad Dermatol       Date:  2019-01-14       Impact factor: 11.527

6.  Chronic active Epstein-Barr virus infection: a bi-faceted disease with inflammatory and neoplastic elements.

Authors:  Ayako Arai
Journal:  Immunol Med       Date:  2019-01-31

7.  Clinicopathologic Features of Hydroa Vacciniforme-Like Lymphoma: A Series of 9 Patients.

Authors:  Mario Magaña; Cesare Massone; Pablo Magaña; Lorenzo Cerroni
Journal:  Am J Dermatopathol       Date:  2016-01       Impact factor: 1.533

8.  Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma.

Authors:  Leticia Quintanilla-Martinez; Cecilia Ridaura; Florian Nagl; Marimar Sáez-de-Ocariz; Carola Durán-McKinster; Ramon Ruiz-Maldonado; Georgia Alderete; Peter Grube; Carmen Lome-Maldonado; Irina Bonzheim; Falko Fend
Journal:  Blood       Date:  2013-08-27       Impact factor: 22.113

Review 9.  Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.

Authors:  Koichi Ohshima; Hiroshi Kimura; Tadashi Yoshino; Chul Woo Kim; Young H Ko; Seung-Suk Lee; Suat-Cheng Peh; John K C Chan
Journal:  Pathol Int       Date:  2008-04       Impact factor: 2.534

10.  Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.

Authors:  Na Guo; Yueqiong Chen; Yu Wang; Yuhua Huang; Yanfen Feng; Min Li; Huilan Rao
Journal:  Diagn Pathol       Date:  2019-07-17       Impact factor: 2.644
View more
  1 in total

Review 1.  Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection.

Authors:  Chien-Chin Chen; Kung-Chao Chang; L Jeffrey Medeiros; Julia Yu-Yun Lee
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.